Loading...
Humana Inc.
HUM•NYSE
HealthcareMedical - Healthcare Plans
$230.48
$3.32(1.46%)
Humana Inc. (HUM) Financial Performance & Statements
Review Humana Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
10.70%
↑ 10.70%
Operating Income Growth
-36.16%
↓ 36.16%
Net Income Growth
-51.51%
↓ 51.51%
Operating Cash Flow Growth
-25.50%
↓ 25.50%
Operating Margin
2.78%
↑ 2.78%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
1.42%
↑ 1.42%
ROE
10.006%
↑ 10.006%
ROIC
10.16%
↑ 10.16%
Humana Inc. (HUM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Humana Inc. stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $29.21B | $29.40B | $29.54B | $29.61B |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $29.21B | $29.40B | $29.54B | $29.61B |
Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $3.84B | $3.28B | $3.08B | $3.01B |
Operating Expenses | $29.76B | $28.67B | $28.40B | $28.38B |
Total Costs & Expenses | $29.76B | $28.67B | $28.40B | $28.38B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $164.00M | $169.00M | $168.00M | $159.00M |
Depreciation & Amortization | $240.00M | $243.00M | $243.00M | $242.00M |
EBITDA | -$303.00M | $971.00M | $1.38B | $1.48B |
EBITDA Ratio | -$0.01 | $0.03 | $0.05 | $0.05 |
Operating Income | -$543.00M | $728.00M | $1.14B | $1.24B |
Operating Income Ratio | -$0.02 | $0.02 | $0.04 | $0.04 |
Other Income/Expenses (Net) | -$356.00M | -$93.00M | -$240.00M | -$246.00M |
Income Before Tax | -$899.00M | $635.00M | $901.00M | $990.00M |
Income Before Tax Ratio | -$0.03 | $0.02 | $0.03 | $0.03 |
Income Tax Expense | $216.00M | $155.00M | $223.00M | $251.00M |
Net Income | -$693.00M | $480.00M | $679.00M | $741.00M |
Net Income Ratio | -$0.02 | $0.02 | $0.02 | $0.03 |
EPS | -$5.75 | $3.99 | $5.64 | $6.13 |
Diluted EPS | -$5.76 | $3.98 | $5.63 | $6.11 |
Weighted Avg Shares Outstanding | $120.41M | $120.41M | $120.44M | $120.98M |
Weighted Avg Shares Outstanding (Diluted) | $120.76M | $120.76M | $120.67M | $121.27M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan